---
schema_version: "secwatch.filing_event.v1"
accession: "0001822479-23-000030"
form_type: "8-K"
ticker: "SHC"
cik: "0001822479"
company_name: "Sotera Health Co"
filed_at: "2023-05-03T23:59:59+00:00"
generated_at: "2026-06-16T01:32:41.664809+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Sotera Health Q1 2023 revenue falls 7% to $221M; net income drops to $3M; reaffirms 2023 outlook

## Summary
- Net revenues $221M, down 6.8% YoY; constant currency down 5.3%, driven by Nordion Cobalt-60 harvest timing.
- Net income $3M ($0.01 diluted EPS) vs $31M ($0.11) in Q1 2022; Adjusted EPS $0.13 vs $0.22.
- Adjusted EBITDA $98M, down 14.6% from $115M; total debt $2.3B, net leverage 3.4x.
- Company reaffirms 2023 outlook despite Q1 declines attributed to expected Nordion harvest schedule timing.

## SEC filing metadata
- accession: 0001822479-23-000030
- form_type: 8-K
- ticker: SHC
- cik: 0001822479
- company_name: Sotera Health Co
- filed_at: 2023-05-03T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822479/000182247923000030/0001822479-23-000030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822479/000182247923000030/shc-20230503.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001822479-23-000030
- JSON: https://secwatch.observer/filing/0001822479-23-000030.json
- Plain text: https://secwatch.observer/filing/0001822479-23-000030.txt

## Key facts
- Earnings Releases
  Sotera Health Co reported the quarter ended March 31, 2023 results: revenue $221 million, net income $3 million, EPS $0.01 per diluted share. Guidance reaffirmed.
  - Period: the quarter ended March 31, 2023
  - Revenue: $221 million
  - Net income: $3 million
  - EPS: $0.01 per diluted share
  - Guidance: reaffirmed
  - Result: reported results
  source text: First-quarter 2023 net revenues decreased 6.8% to $221 million, compared with $237 million in the first-quarter 2022. Net revenues decreased 5.3% on a constant currency basis. Net income (“net income”) was $3 million, or $0.01 per diluted share, compared with net income of $31 million, or $0.11 per diluted share in the first-quarter 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1822479/000182247923000030/0001822479-23-000030-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.